Page 8 - 2019 MPMA Summer Profiles
P. 8

Electronic Diabetes Devices




            Offer Disease Management



            for Podiatric Doctors









                                                           eople with diabetes are turning to electronic skin patches and
                                                           their phones to control their diabetes instead of pricking their
                                                    Pfingers.
                                                       Patients are now wearing coin-sized skin patches on their arms or
                                                    abdomens to test their blood-sugar levels automatically, then send the
                                                    data to their smartphone or to a wearable insulin pump that delivers the
                                                    medicine.
                                                       Known as continuous-glucose monitors, these devices are becoming
                                                    more popular. In the U.S. their use has nearly doubled from 389,000 at
                                                    the end of 2017 to 840,000 as of March 2019.
                                                       Digital blood-sugar monitors hit the market in the mid-2000s and has
                                                    soared because the devices have become more accurate and more health
                                                    plans are paying for them.
                                                       The disposable sensors can be worn around the clock. They stick to
                           Dr. Shawn Reiser         a patient’s abdomen or arm and insert a tiny needle into the skin to sense
                                                    changes in blood-sugar and transmit readings wirelessly. Some patients
                                                    have the glucose data sent to a wearable insulin pump; some pumps can
                                                    adjust the dose based on the glucose reading.
                                                       Some monitors sound alarms and keep track of long-term data, which
                          I had one
                                                    patients can share with their physicians.
               patient who went from                   MPMA member Dr. Shawn Reiser from Community Podiatry Group

               a hemoglobin A-1 C of                in Flint, MI feels the technology is key to diabetes control.
                                                       “Continuous glucose monitoring helps my patients better manage
               12.5mg/dL to 8.5mg/                  their blood sugar. I had one patient who went from a hemoglobin A-1C of

               dL within the first six              12.5mg/dL to 8.5mg/dL within the first six months of having the device.
                                                    It’s super handy because everything is on their phone and can easily be
               months of having the                 shared in one log to their doctor. It also adds a convenience factor that

               device. I hope as time               cannot be overlooked. For example, if a patient is exercising and they
                                                    don’t feel like themselves they automatically know their blood sugar level
               goes on more and more
                                                    by checking their phone. Then they can do what is necessary to take hold
               of my patients will have             of the situation before it gets out of control. I hope as time goes on more
               access to continuous                 and more of my patients will have access to CGM.”
                                                       Controlling diabetes is a complex job that affects approximately
               glucose devices.”                    1,055,253 people in Michigan.

                     —Dr. Shawn Reiser
                                                                                             Continued on page 20







          8  MICHIGAN PODIATRIC MEDICAL ASSOCIATION
   3   4   5   6   7   8   9   10   11   12   13